Status:
RECRUITING
(3D) Ultrasound Imaging Liver and Kidney
Lead Sponsor:
Western University, Canada
Conditions:
Liver Cancer
Kidney Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study is to assess the addition of 3D ultrasound guidance during standard care ablation or biopsies of liver or kidney tumours. 3D ultrasound only differs from conventional 2D ultrasound in that ...
Detailed Description
Images will be acquired by a physician on patients who are undergoing a liver or kidney ablation or biopsy procedure who are well enough to provide consent. Patients will be imaged during the ablation...
Eligibility Criteria
Inclusion
- • Patients who are scheduled for standard care liver or kidney ablation or biopsy
Exclusion
- None
Key Trial Info
Start Date :
October 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03844399
Start Date
October 3 2020
End Date
February 1 2027
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria Hospital
London, Ontario, Canada, N6A 5W9